Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_assertion type Assertion NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_head.
- NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_assertion description "[The most consistent results are the increased gastric cancer risk associated with IL1B and NAT1 variants, which may account for up to 48% of attributable risk of gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_provenance.
- NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_assertion evidence source_evidence_literature NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_provenance.
- NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_assertion SIO_000772 12115538 NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_provenance.
- NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_assertion wasDerivedFrom befree-2016 NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_provenance.
- NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_assertion wasGeneratedBy ECO_0000203 NP360916.RA5zhGhcXhGmj0YmUm2yTiALDr8S-apDIyWa-EVKqSMrc130_provenance.